ClinVar Miner

Submissions for variant NM_022124.6(CDH23):c.5066T>C (p.Met1689Thr)

gnomAD frequency: 0.00002  dbSNP: rs397517334
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000039198 SCV000062882 likely benign not specified 2012-09-22 criteria provided, single submitter clinical testing Met1689Thr in exon 39 of CDH23: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including mammals. Of note, more than 20 different mammals have a threonine (Thr) at this position des pite high nearby amino acid conservation. In addition, computational analyses ( biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) suggest that the Met1689Thr variant may not impact the protein.
Illumina Laboratory Services, Illumina RCV000281904 SCV000363775 uncertain significance Autosomal recessive nonsyndromic hearing loss 12 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Illumina Laboratory Services, Illumina RCV000318225 SCV000363776 uncertain significance Usher syndrome type 1D 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000912043 SCV001057128 likely benign not provided 2024-01-24 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000281904 SCV001781356 uncertain significance Autosomal recessive nonsyndromic hearing loss 12 2021-07-14 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000318225 SCV001781357 uncertain significance Usher syndrome type 1D 2021-07-14 criteria provided, single submitter clinical testing
GeneDx RCV000912043 SCV001981941 uncertain significance not provided 2021-08-20 criteria provided, single submitter clinical testing Identified in a patient who harbored a causative deletion in the NDP gene and classified as an incidental finding in published literature (Sudha et al., 2017); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28602015)
Revvity Omics, Revvity RCV000912043 SCV003831036 uncertain significance not provided 2019-11-04 criteria provided, single submitter clinical testing
GenomeConnect, ClinGen RCV000844910 SCV000986717 not provided Autosomal recessive nonsyndromic hearing loss 12; Usher syndrome type 1D no assertion provided phenotyping only Variant interpretted as Uncertain significance and reported on 01/15/2018 by GTR ID Blueprint Genetics. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.
Natera, Inc. RCV001272904 SCV001455328 likely benign Usher syndrome type 1 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.